StockWatch
·
 Medicinal Chemicals and Botanical Products
PartnershipJun 25, 2026, 04:42 PM

UPEXI Enters Advisory Agreement with Hivemind Capital

AI Summary

UPEXI, Inc. has entered into an Advisory Services Agreement with Hivemind Capital Partners, LLC, effective June 22, 2026. Under the three-year agreement, Hivemind will provide advisory and consulting services for UPEXI's business, operations, and capital markets strategies. Compensation will be paid quarterly in common stock shares, equivalent to 0.3125% of UPEXI's market capitalization per quarter, with a 9.99% beneficial ownership share cap for the Advisor, beyond which fees are paid in cash. The company will also provide registration rights for these shares.

Key Highlights

  • UPEXI entered an Advisory Services Agreement with Hivemind Capital Partners, LLC on June 22, 2026.
  • The agreement has an initial term of three years, renewable for successive one-year periods.
  • Compensation is a quarterly advisory fee paid in common stock shares.
  • The quarterly fee is 0.3125% of the company's market capitalization (1.25% annually).
  • A Share Cap prevents the Advisor from beneficially owning over 9.99% of outstanding common stock.
  • Fees exceeding the Share Cap will be paid in cash.
  • UPEXI will provide customary registration rights for the Advisory Fee Shares, including Form S-3 filing.